|

Investors Corner
The market
UK blue chips ended higher on Friday after a fairly quiet final
session of a volatile week, finishing well below early morning
highs as Wall Street put in a cautious and mixed early performance
after some worrying US data. Strength in selected old
economy issues, and some window dressing ahead of the
end of the quarter, and the end of the tax year on 4 April,
provided the only real support in London, countered by fresh
falls from new economy stocks.
At the Friday close, the FTSE 100 index was 45.3 points firmer
at 5,633.7, below a peak of 5,664.8 recorded at 9.04am, but
well above a low of 5,574.1 registered almost at open. All the
broader FTSE indices were firm, aside from the TechMARK 100
index off 15.64 points at 1,927.58. Volume in London
was moderate, with 1.857 billion shares changing hands in 116,452
transactions.
After moving lower at the Friday start following a mixed overnight
performance in New York, leading shares soon picked up, rallying
in to the blue helped by initial rallies from telecoms issues
as investors sought out attractively valued new economy
stocks following the recent sell-off in reaction to Nortels
warning.
However, a lack of follow-through buying soon reversed the trend
for telecom issues, which turned lower with some inevitable
profit-taking as the morning session progressed, with technology
stocks also cold shouldered again after Nasdaqs overnight
falls. A lack of any key UK economic pointers to provide any
alternative direction also kept blue chips off their best levels,
with the main focus directed towards a key batch of US data
due late afternoon in London.
The Chicago Purchasing Management Association saw its key index
of regional business activity fall to 35.0 in March, down from
43.2 in February, while market forecasters had predicted an
increase to 44.0-44.5. The final University of Michigan consumer
sentiment index was revised down to 91.5 in March, against a
91.8 preliminary reading.
Analysts pointed out that the big drop in the key Chicago PMI
reading had spooked Wall Street, showing the continuing impact
of the US economic slow down, although the news could also be
seen as adding to the case for further Fed. interest rate cuts
in the near future.
But, in reaction to the Chicago PMI news, the DJIA saw a wobble
after its early gains, while the Nasdaq composite index turned
lower, affected too by another earnings warning from a US technology
firm with semiconductor firm Cirus Logic cautioning that
its profits for the next two quarters will not meet Wall Street
expectations citing inventory charges. As a result, by the London
close, the DJIA was 25.40 points firmer at 9,824.46, but the
Nasdaq composite index was 12.65 points lower at 1,807.92.
Old economy issues dominated on the blue chips leaders
board, with drug stocks making most of the running thanks to
their defensive attractions. AstraZeneca finished off its best
levels but still got a good boost from news it is seeking FDA
approval for its Faslodex breast drug after successfully completing
clinical trials. AstraZeneca shares took on 116 pence at 3,360.
Fellow drugs blue chip Nycomed Amersham saw support again, up
25-1/2 pence at 491, continuing to be helped by Merrill Lynchs
recent upgrade to buy. GlaxoSmithKline also found
gains, adding 48 pence at 1,841, while Celltech Group topped
the FTSE 100 gainers, rallying 64 pence higher to 1,210. But
Shire Pharmaceuticals failed to join in, running in to profit
taking after its strong gains over the past few sessions. Shire
shares had seen a good boost this week on arbitrage-linked short
selling following news that the groups completion of its
agreed takeover of Nasdaq-listed Biochem has been delayed by
the Canadian government.
Elsewhere, back among the blue chips gainers, financial issues
found support, lifted by fresh consolidation hopes in the wake
of news that Allianz is in talks with Dresdner Bank, and as
rumours circulated that Citibank is casting an eye over American
Express. Fund management groups stood out, with Schroders gaining
37 pence at 1,055 and Amvescap adding 33 at 1,025.
Among banking issues, Abbey National stood out, firming 32 pence
at 1,124 as investors assessed the bid situation surrounding
the group following the UK Competition Commissions ground
breaking public hearing into Lloyds TSBs proposed takeover
of the firm. Speaking after the meeting, Lloyds TSB deputy chief
executive Mike Fairey said that he was relatively confident
that Lloyds TSB will clear all regulatory hurdles and be given
the go-ahead by the Competition Commission to take over Abbey
National. Lloyds TSB shares firmed 3-1/2 pence at 691-1/2.
Meanwhile, Rio Tinto also saw good gains, adding 35 pence at
1,225, after Lehman Brothers initiated coverage with a buy
rating, pointing out that the mining groups diversified
focus offers more opportunities to grow. GUS, up 14 pence at
495, received a boost from news of the disposal of its KC Finance
unit to Close Brothers for £50.4 million.
ARM Holding was also a blue chip gainer, bucking the otherwise
dull trend in the technology sector and the profit warning
from US chip maker Cirrus Logic thanks to a spot of bargain
hunting. ARM shares took on 13 pence at 329. However, other
technology blue chips suffered a down turn after recent recoveries,
affected by Nasdaqs retreat amid continuing earnings concerns.
Powergen
Powergen, the electricity generator, distributor and supplier,
reported that its UK business performed ahead of expectations
last year. The companys integrated approach continued
to deliver value, confirming that it had the correct model for
the UK market in todays competitive environment. Its retail
business passed the three million customer account mark providing
profitable growth through getting more customers and selling
more products. Energy trading continued as the hub of its integrated
business, co-ordinating its market actions and maximising the
value of its generation and customer assets.
Powergens production business provided low cost generation
giving flexible options to its energy trading business. In distribution,
Powergen is nearing completion of its cost saving initiatives,
proving that its asset management skills are just as relevant
in distribution as they are in generation.
UK Electricity prices stabilised in the second half of 2000
with annual baseload contracts at around £19/MWh. Powergens
hedging policy meant that the impact of lower prices from February
2000 only started to have a material impact in the fourth quarter
of 2000. Nevertheless, these lower prices will have an impact
for the whole of 2001. Higher gas prices are expected to have
a small effect on profits. Powergens generation output
and gas costs are largely hedged through 2001. However, this
position will move throughout the year and Powergen is hoping
to take on these opportunities to secure additional value as
they arise.
The New Electricity Trading Arrangements (Neta) are scheduled
for introduction on 27 March. For Powergen, with its flexible
generation, growing customer base and integrated trading strategy,
Neta represents a business opportunity rather than a threat.
With its strong national brand Powergen should continue to build
on the successes of its winning retail business. Powergen exceeded
its three million customer account milestone late in 2000 and
now has the products and sales infrastructure to achieve its
target of five million by the end of 2002.
Its focus for 2001 in the residential market is expected to
continue to grow its customer base organically, while ensuring
it retains its existing customers and cross sell new products
to them. The Small & Medium Enterprise (SME) market continues
to be Powergens fastest growing and most profitable retail
business segment achieving 53 per cent growth during the year.
Across the Atlantic, Powergen completed its acquisition of LG&E
on 11 December. Although the transaction took just over nine
months to close, Powergen was able to spend the time before
completion working with LG&E to benchmark their business
against worlds best practice. Efficiency improvements,
to be delivered over the next three years, will be greater than
initial expectations and LG&E has already announced a voluntary
severance package.
Initial indications are that the take up for this package will
be good, with staff reductions to be phased in to ensure no
loss of service quality. Operationally, LG&E has had a good
year in both the regulated utility operations of LG&E and
Kentucky Utilities (KU), and in their unregulated businesses.
The acquisition of LG&E cost £2,258 million and created
goodwill of £1,498 million. As a result gearing, defined
as debt as a proportion of total capital, increased to 70 per
cent at the year end.
Having set itself a target of reducing debt by £1 billion
through the sale of assets in the UK and overseas, Powergen
reported that it is expected to exceed this sum. Overall the
asset sale programme is on target to reduce debt by around £1.25
billion.
Powergen decided to retain Connahs Quay in the UK and
is still reviewing the options for its assets in Germany and
Hungary.
Due to abnormal weather conditions, system demand was up 2.2
per cent on the previous year to 301.6 TWh. High availability
from Powergen plant, together with an increase in outages from
competitors, allowed for an increase in output. Powergen generated
43.2 TWh, a market share of 14.3 per cent up slightly compared
with output from the same plant in 1999. Looking ahead and allowing
for the impact of the sale of the two plants, Powergen expects
to generate around 30 TWh in 2001 (around 10 per cent market
share).
Looking ahead, distribution will continue to be a core part
of Powergens business strategy. Should the opportunity
arise, and if at the right price, the company would seriously
consider the purchase of a second distribution business to build
on what has been delivered at East Midlands. Powergen is also
actively looking at asset management opportunities in managing
other distribution assets owned by others. Overall, Powergen
has either met, or exceeded, all of the objectives that it set
for itself last year. Powergen has transformed itself during
the year 2000 into a business well positioned to take advantage
of opportunities that will arise from the developing competitive
markets in the UK and the US.


|